Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

The fractalkine receptor CX3CR1 is a key mediator of atherogenesis
Myron I. Cybulsky, Robert A. Hegele
Myron I. Cybulsky, Robert A. Hegele
Published April 15, 2003
Citation Information: J Clin Invest. 2003;111(8):1118-1120. https://doi.org/10.1172/JCI18237.
View: Text | PDF
Commentary

The fractalkine receptor CX3CR1 is a key mediator of atherogenesis

  • Text
  • PDF
Abstract

Authors

Myron I. Cybulsky, Robert A. Hegele

×

Total citations by year

Year: 2024 2022 2017 2015 2010 2009 2007 2006 2004 Total
Citations: 1 2 1 2 1 2 1 1 1 12
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (12)

Title and authors Publication Year
Chemokine Fractalkine and Non-Obstructive Coronary Artery Disease-Is There a Link?
Stangret A, Sadowski KA, Jabłoński K, Kochman J, Opolski G, Grabowski M, Tomaniak M
International journal of molecular sciences 2024
Myeloid leukocytes' diverse effects on cardiovascular and systemic inflammation in chronic kidney disease.
Hof A, Geißen S, Singgih K, Mollenhauer M, Winkels H, Benzing T, Baldus S, Hoyer FF
Basic Research in Cardiology 2022
Increased frequency of proangiogenic tunica intima endothelial kinase 2 (Tie2) expressing monocytes in individuals with type 2 diabetes mellitus
Reijrink M, van Ark J, Lexis CP, Visser LM, Lodewijk ME, van der Horst IC, Zeebregts CJ, van Goor H, de Jager SC, Pasterkamp G, Wolffenbuttel BH, Hillebrands JL
Cardiovascular Diabetology 2022
Rare genetic variants in CX3CR1 and their contribution to the increased risk of schizophrenia and autism spectrum disorders
Ishizuka K, Fujita Y, Kawabata T, Kimura H, Iwayama Y, Inada T, Okahisa Y, Egawa J, Usami M, Kushima I, Uno Y, Okada T, Ikeda M, Aleksic B, Mori D, Someya T, Yoshikawa T, Iwata N, Nakamura H, Yamashita T, Ozaki N
Translational Psychiatry 2017
CX3CR1 deficiency delays acute skeletal muscle injury repair by impairing macrophage functions
W Zhao, H Lu, X Wang, RM Ransohoff, L Zhou
The FASEB Journal 2015
Vascular Smooth Muscle Cells From Hypertensive Patient-Derived Induced Pluripotent Stem Cells to Advance Hypertension Pharmacogenomics
NM Biel, KE Santostefano, BB DiVita, NE Rouby, SD Carrasquilla, C Simmons, M Nakanishi, RM Cooper-DeHoff, JA Johnson, N Terada
Stem Cells Translational Medicine 2015
Silencing CX3CR1 production modulates the interaction between dendritic and endothelial cells
X Liu, G Lu, J Shen
Molecular Biology Reports 2010
NF-kappaB activity in endothelial cells is modulated by cell substratum interactions and influences chemokine-mediated adhesion of natural killer cells
S Hess, H Methe, JO Kim, ER Edelman
Cell transplantation 2009
Search for an Association between V249I and T280M CX3CR1 Genetic Polymorphisms, Endothelial Injury and Preeclampsia: The ECLAXIR Study
Stepanian A, Benchenni S, Beillat-Lucas T, Omnes S, Defay F, Peynaud-Debayle E, Baron G, Le Querrec A, Dreyfus M, Salomon L, Tsatsaris V, de Prost D, Mandelbrot L
PloS one 2009
Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques
Frank Tacke, David Alvarez, Theodore J. Kaplan, Claudia Jakubzick, Jaime Llodra, Rainer Spanbroek, Alexandre Garin, Jianhua Liu, Matthias Mack,Nico van Rooijen, Sergio A. Lira, Andreas J. Habenicht, Gwendalyn J. Randolph
Journal of Clinical Investigation 2007
Importance of LXR-alpha transcriptome in the modulation of innate immunity.
Kaul D, Gautam A, Sikand K
Molecular and Cellular Biochemistry 2006
The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines
M Weber, E Blair, CV Simpson, M O'Hara, PE Blackburn, A Rot, GJ Graham, RJ Nibbs
Molecular biology of the cell 2004

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts